MoonLake Immunotherapeutics (MLTX)
Nasdaq: MLTX · Pharmaceutical Preparations · Zug, CH · filing with the SEC since 2020
Who runs MoonLake Immunotherapeutics
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Santos Da Silva Jorge
Chief Executive Officer. First filing Apr 2022, latest Jul 13, 2026, 7 filings in all.
Officers reporting now
4
of 18 people with a filing in the last fifteen months
Directors reporting now
14
25 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Reich Kristian | Chief Scientific Officer | Apr 2022 | Jul 29, 2026 | 10 · $8.1M |
| Santos Da Silva Jorge | Chief Executive Officer | Apr 2022 | Jul 13, 2026 | 7 · $8.7M |
| Bodenstedt Matthias | Chief Financial Officer | Apr 2022 | Jun 23, 2026 | 7 · $3.2M |
| Chen Bihua | CEO and Chairman | Oct 2020 | Oct 1, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Biotechnology Value Fund II LP | director | Apr 2022 | Jun 22, 2026 | none |
| Biotechnology Value Fund L P | director | Apr 2022 | Jun 22, 2026 | none |
| Biotechnology Value Trading Fund Os LP | director | Apr 2022 | Jun 22, 2026 | none |
| Bvf Gp Holdings LLC | director | Apr 2022 | Jun 22, 2026 | none |
| Bvf I Gp LLC | director | Apr 2022 | Jun 22, 2026 | none |
| Bvf II Gp LLC | director | Apr 2022 | Jun 22, 2026 | none |
| Bvf Inc/il | director | Apr 2022 | Jun 22, 2026 | none |
| Bvf Partners L P/il | director | Apr 2022 | Jun 22, 2026 | none |
| Bvf Partners Os Ltd. | director | Apr 2022 | Jun 22, 2026 | none |
| Lampert Mark N | director | Apr 2022 | Jun 22, 2026 | 3 · $63.0M |
| Loy Spike | director | Apr 2022 | Jun 18, 2026 | none |
| Moukheibir Catherine | director | Apr 2022 | Jun 18, 2026 | none |
| Phillips Andrew John | director | Apr 2022 | Jun 18, 2026 | none |
| Xavier Ramnik | director | Apr 2022 | Jun 18, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% owner | Oct 2023 | Oct 1, 2025 | none |
| Cormorant Global Healthcare Master Fund, LP | 10% owner | Oct 2023 | Oct 1, 2025 | 1 · $0.00 |
| Cormorant Private Healthcare Fund II, LP | 10% owner | Oct 2023 | Oct 1, 2025 | none |
| Cormorant Private Healthcare Fund III LP | 10% owner | Oct 2023 | Oct 1, 2025 | none |
| Cormorant Private Healthcare Fund IV LP | 10% owner | Oct 2023 | Oct 1, 2025 | none |
Earlier names on the record7, newest filing first
Sturge Simon · director · last filing Jun 2025Lassen Kara · director · last filing Apr 2022Helix Holdings LLC · director · last filing Apr 2022Scollins Jay · officer · last filing Oct 2020Chang Nancy T · director · last filing Oct 2020Lewis Will · director · last filing Oct 2020Schmid John P. · director · last filing Oct 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.